Related Experiment Videos
Resampling-based methods for the analysis of multiple endpoints in clinical trials
1GSF National Research Center for Environment and Health, Medis-Institut, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany. reitmier@gsf.de
Statistics in Medicine
|December 28, 1999
Summary
This study introduces resampling-based cut-off tests for comparing two treatments with multiple endpoints. These novel methods significantly improve statistical power compared to traditional approaches, especially in multivariate one-sided tests.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Statistical Inference
Background:
- Multivariate tests are crucial for comparing treatments with multiple endpoints.
- Traditional cut-off tests can be overly conservative due to unaddressed endpoint dependencies.
- Existing methods may lack power when treatment effects vary across endpoints.
Purpose of the Study:
- To develop improved multivariate tests for comparing two treatments across multiple endpoints.
- To enhance the statistical power of cut-off tests by incorporating resampling methods.
- To create tests sensitive to treatment differences in single, multiple, or all endpoints.
Main Methods:
- Development of resampling-based cut-off tests.
- Utilizing Monte Carlo simulations to evaluate test performance.
- Comparison with crude simultaneous consideration of univariate tests.
- Application to data from a clinical trial.
Main Results:
- Resampling-based methods significantly improve the performance of cut-off tests.
- Demonstrated remarkable gains in statistical power compared to conventional methods.
- Proposed tests show sensitivity to treatment differences across various endpoint combinations.
- Effectiveness validated through Monte Carlo simulations.
Conclusions:
- Resampling-based cut-off tests offer a powerful and sensitive approach for multivariate treatment comparisons.
- These methods are particularly recommended for multivariate one-sided test situations.
- The proposed tests provide a valuable advancement for analyzing clinical trial data with multiple endpoints.